The US has stopped using Janssen, why are we'introduced as expected'?

<Anchor> We

will continue talking about vaccines with medical reporter Cho Dong-chan.

[Dong-chan Cho/medical reporter (specialist): It is because I don't think that the chance of naturally occurring thrombotic side effects after Janssen's vaccination has been exceeded.

It's a little different from the AstraZeneca vaccine. Shall we look at the screen?

Among 100,000 people, cerebral blood clots occurred spontaneously for 2 weeks in their 20s, in 0.05 in their 20s and in 1.29 in their 30s and 40s. It was 8.5 times more than the natural occurrence rate.

The 50s were also a little high, but the natural incidence rate did not exceed the 60s and above.

For this reason, some countries have restricted vaccination only to those under the age of 60, but the Janssen vaccine is 6 out of 6.5 million.

In other words, about 1 in 1 million people.

Analysis by age has not been finished yet, but it is unlikely that the natural incidence rate will be exceeded, which is why the Korean government will introduce it as scheduled.]

[Cho Dong-chan/medical reporter (specialist): It is not there in other vaccines, but Janssen is attracting attention because of the manufacturing method. Let’s watch the video. The AstraZeneca vaccine uses an adenovirus shell that eliminates toxicity. Some of the corona 19 virus genes were put into it as a kernel. The shell only serves as a transport and the kernel induces an immune response, and Janssen vaccine also uses an adenovirus shell. If this is the cause of blood clots, Janssen is also at risk of blood clots. The kernel is a little different from Janssen and AstraZeneca. Janssen may not be dangerous if the kernel of the AstraZeneca vaccine is the cause of the blood clot. Domestic vaccine experts seem to be the cause of the kernel, so Janssen seems to be okay. There are many opinions like this, but it has not been concluded yet. The US is also trying to avoid such a rare risk, probably because it has enough Pfizer and Modena.]

[Dong-Chan Cho/medical reporter (specialist): First of all, the monopoly of vaccines by the vaccine producing countries seems to have to be co-responded with the World Health Organization. It has been shown to be better and has no side effects of blood clots, and in this case, the number of vaccinations can be doubled. If Korea conducts its own clinical trials, it seems to be able to help to some extent in solving the lack of vaccines.]  

▶ Temporarily suspending Janssen vaccination… Moder or “US first supply”

▶ There is no vaccine to replace… I need to rewrite the vaccination plan.